How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

229 results for

Microdermabrasion

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects

on treatment for more than 2 consecutive weeks prior to start of investigational product use). Used the following agents on the face or performed the following procedure within the previous 4 weeks:Topical corticosteroids (Use of inhaled, intra-articular, or intra-lesional steroids other than for facial acne is acceptable);Facial procedure (such as chemical or laser peel, microdermabrasion, blue light treatment, etc.). Used systemic retinoids within the previous 6 months or topical retinoids on the face

2011 Clinical Trials

162. Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)

hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days of initiation of treatment. Cryotherapy within 2 weeks of initiation of treatment Retinoids, including tazarotene, adapalene, tretinoin, retinol, within 4 weeks of initiation of treatment. Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-FU, diclofenac, imiquimod or other topical treatments for AK within 8 weeks of initiation of treatment. Two or more ALA PDT

2011 Clinical Trials

163. Aesthetic Dermatology for Aging Ethnic Skin. (Abstract)

Medline literature search was performed for publications on the safety and efficacy of botulinum toxin, dermal fillers, chemical peels, laser and light-based devices, and microdermabrasion for the treatment of skin aging specifically in ethnic populations.Similarly to light-skinned patients, botulinum toxin and dermal fillers provide fast, effective results in skin of color, with fewer complications than with traditional surgery and no downtime. More-invasive procedures, such as chemical peeling (...) , laser resurfacing, and microdermabrasion, can also be effective, but it is important to exercise caution and remain within certain parameters given the greater risk of dyschromias in this population.With the proper knowledge of how to treat aging skin of color, these patients can experience the benefits of cosmetic procedures while minimizing the risks.© 2011 by the American Society for Dermatologic Surgery, Inc.

2011 Dermatologic Surgery

164. Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

weeks prior to start of investigational product use). Used the following agents on the face or performed the following procedure within the previous 4 weeks: Topical corticosteroids (Use of inhaled, intra-articular, or intra-lesional steroids other than for facial acne is acceptable); Facial procedure (such as chemical or laser peel, microdermabrasion, blue light treatment, etc.). Used systemic retinoids within the previous 6 months or topical retinoids on the face within the previous 6 weeks

2011 Clinical Trials

165. Study of Laser Treatment of Melasma

Nd:YAG Laser System With Smart Infinite (SI) Handpiece for the Treatment of Refractory Mixed Type Melasma Study Start Date : April 2011 Actual Primary Completion Date : March 2012 Actual Study Completion Date : March 2012 Arms and Interventions Go to Arm Intervention/treatment Experimental: Laser treatment Laser treatment added to microdermabrasion and topical lightening agent regimen Device: Q-Switched Nd:YAG Laser (RevLite) Laser treatment added to a microdermabrasion and topical lightening agent

2011 Clinical Trials

166. A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging

period (e.g. other types of chemical peelings, microdermabrasion, etc.); Individuals with significant medical history, concomitant disease or condition in which the investigator believes that participation in the study is not propitious; Patients with known sensitivity to retinoids or to any component of the study products; Patients with a diagnosis or history of keloids; Patients without the minimum wash-out period for the following treatments: 2 weeks for topical alpha- hydroxy acid, glycolic acid (...) , salicylic acid, lactic acid, betahydroxy acid on the face. 2 weeks for topical products containing vitamin A, ascorbic acid, vitamin E on the face. 2 weeks for topical corticosteroids. 4 weeks for systemic corticosteroids. 3 months for topical retinoids. 1 year for oral retinoids. Patients who underwent superficial chemical peelings, microdermabrasion or exfoliation on the face in the last 3 months; Patients who applied botulinum toxin or soft tissue fillers for facial rejuvenation in the last 6 months

2011 Clinical Trials

167. 5fluorouracil for Advanced Photoaging

-hydroxyacids, poli-hydroxyacids, beta-hydroxyacids and ascorbic acid in the last 3 months; Treatment by chemical peeling, microdermabrasion and non-ablative laser in the last 3 months; Treatment with systemic retinoid in the last 6 months ; Chemotherapy in the last 3 months; Hypersensibility to parabens; Infectious or inflammatory dermatosis on forearms; Clinical evidence of immunosuppression and Presence of photodermatosis Contacts and Locations Go to Information from the National Library of Medicine

2011 Clinical Trials

168. A prospective study of the efficacy of the N-Lite laser for the treatment of facial wrinkles. Full Text available with Trip Pro

with microdermabrasion did not seem to affect the final result. In those patients where wrinkle reduction was seen, changes were subtle and not impressive.We did not find the N-Lite 585-nm nonablative laser to be a predictable or efficacious way to treat facial wrinkles. More extensive studies of the laser and treatment protocols must be performed to justify acceptance of this product in the marketplace.

2009 Aesthetic surgery journal Controlled trial quality: uncertain

169. Atralin Gel for the Treatment of Rosacea

in the past 4 weeks. Use of systemic retinoids within the past 6 months. Use of topical retinoids within the past 3 months Use of laser or light based rosacea treatments within the past 2 months. Cosmetic procedures (e.g., superficial chemical peels, exfoliation or microdermabrasion of the face) within the past two months Use of topical anti-aging medications including alpha hydroxy acids, salicylic acid, beta-hydroxy acid, vitamin A, vitamin E, ascorbic acid Other dermatologic conditions that require

2010 Clinical Trials

170. Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots

Years (Adult) Sexes Eligible for Study: Female Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Able to understand and sign informed consent. Able to complete study and comply with study procedures. Caucasian female ages 25-55. Presence of photodamage and lentigines of II-III on the Glogau Photoaging Must be willing to avoid laser and light treatments, treatments with filler, chemical peels, microdermabrasion, Botox or any other cosmetic treatment to the face during the duration (...) of the study. Must be willing to avoid changing topical moisturizers and cosmetics during the study. Able to stop any alpha or beta hydroxy acids, topical retinol or retinoid derivatives, topical antioxidants, or any topical product that may interfere with the study 2 weeks prior to the study. Exclusion Criteria: Cosmetic treatment of face, such as laser or light treatment, filler, Botox, microdermabrasion, or chemical peels 6 months prior to study or during study. Current smoker. Pregnant, nursing

2010 Clinical Trials

171. Safety & Effectiveness of the BEAM Device in Mild-to-moderate Acne

months of entry into the study. Systemic acne therapies (oral antibiotics) within 2 weeks of entry into the study. Topical acne therapies (retinoids, antibiotics) within 1 week of entry into the study. Microdermabrasion or superficial chemical peels at the site to be treated within 2 months of entry into the study. Subjects with a history of dermabrasion or laser resurfacing at the site to be treated. Use of topical lipid absorbing substances (Clinac AC) within 1 week of entry into the study. Non

2010 Clinical Trials

172. Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI

not agree to refrain from any other type of facial skin resurfacing (e.g., microdermabrasion, laser or IPL treatment, chemical peel) or injected filler/other substances (e.g., Restylane, Botox) that might affect the treatment area for the duration of the study Underlying silicone or other nonabsorbable fillers in the treatment area or has had filler (e.g., collagen, fat) injections within the past 3 months History of keloidal scarring or nodulocystic acne Phenol or chemical peel or dermabrasion

2010 Clinical Trials

173. Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

to assess facial wrinkles in the mirror (contact lenses OK) Exclusion Criteria: Current or previous botulinum toxin treatment of any serotype Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis Prior facial cosmetic surgery (e.g., prior periorbital surgery, facial lift, brow lift, eyelid lift or eyebrow surgery) Facial laser or light treatment, microdermabrasion, or superficial peels within 3 months Oral retinoid therapy within one year Contacts and Locations Go

2010 Clinical Trials

174. Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

, microdermabrasion or superficial peels within 3 months Oral retinoid therapy within 1 year Prior facial cosmetic surgery (eg, periorbital surgery, facial lift, brow lift, eye lift, or eyebrow surgery) Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please

2010 Clinical Trials

175. Injectable Filler for Cheek Flattening

and/or quality of photography. Subjects who have had soft tissue augmentation of the malar area in the previous 6 months. Permanent or semi-permanent dermal fillers in the malar area. Ablative skin resurfacing on the malar area within the previous 6 months or during the study. Retinoid, microdermabrasion, or prescription level glycolic acid treatments to the malar area within 2 weeks prior to study participation or during the study. Active infection in the malar area (e.g., acute acne lesions or ulcers

2010 Clinical Trials

176. Evaluation of a Photopneumatic System for the Treatment of Acne

requirements. Exclusion Criteria: Subjects must not have active localized or systemic infections. Subjects must not have a compromised ability for wound healing, such as: malnutrition, steroid use, history of collagen vascular disease (e.g. lupus, scleroderma, history of keloid scar formation), atrophic dermatitis or immunologic abnormalities such as vitiligo. Subjects must not have received microdermabrasion within one (1) month prior to enrollment. Subjects must not have received immunosuppressive

2010 Clinical Trials

177. A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines

or over the counter) medicated creams, lotions, gels, balms, powders, etc. on the treatment areas during the study period A patient receiving any topical products containing alpha-hydroxy acids, salicylic acid, and vitamins C or D (includes derivatives thereof) on the perioral or lateral canthal areas within 7 days prior to or during the study period, other than the study products A patient receiving any investigational drug and/or has had a microdermabrasion (light or medium skin peel) treatment

2010 Clinical Trials

178. Apremilast in the Treatment of Moderate to Severe Acne

the study. Subjects who have had a facial procedure (chemical or laser peel, blue light treatment, microdermabrasion, etc) within 4 weeks before enrollment or during the study. Any condition, including the presence of laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study Subjects who abuse drugs or alcohol (drug screening not required). Pregnant, trying to become pregnant

2010 Clinical Trials

179. Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses

(greater than 2%) within 2 days of initiation of treatment. · Retinoids, including tazarotene, adapalene, tretinoin, retinol, within 4 weeks of the initiation of treatment.· 5-FU, cryotherapy, diclofenac, imiquimod or other treatments for AK within 8 weeks of initiation of treatment.· Microdermabrasion, laser ablative treatments or chemical peels within 8 weeks of the initiation of treatment. · ALA-PDT within 6 months of initiation of treatment. 14. Subject has used any of the following systemic

2010 Clinical Trials

180. Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

2 weeks prior to study entry. Any skin condition or disease that may require concurrent therapy or may confound the evaluation; History of hypersensitivity to any of the formulation components; Facial skin cancer or facial actinic keratosis; Use of any photosensitizing agents. Use of isotretinoin within the last 6 months. Chemical peels, microdermabrasion or laser resurfacing within 3 months of study entry. Crohns disease, ulcerative colitis, or have developed colitis with past antibiotic use

2010 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>